A study on how HNRNPA2B1 affects the sensitivity of advanced prostate cancer to CDK4/6 inhibitor treatment

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 8ffe9c38555d1d49da4faa1f4353cfe5f7edf554
First added on: Oct 10, 2026